These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21897595)

  • 1. Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India.
    Pathak S; Chandrashekhar M; Wankhede GR
    Asian J Transfus Sci; 2011 Jul; 5(2):153-6. PubMed ID: 21897595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study.
    Pokhrel A; Jain A; Marwaha N; Singh RS
    Asian J Transfus Sci; 2022; 16(1):1-6. PubMed ID: 36199399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type and screen policy: is there any compromise on blood safety?
    Agrawal A
    Transfus Apher Sci; 2014 Apr; 50(2):271-3. PubMed ID: 24472664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.
    Mathur A; Jindal A; Tiwari AK; Bhuyan D; Jagannathan L; Sawant RB; Basu S; Reddy M; Datta SS
    Immunohematology; 2022 Sep; 38(3):100-105. PubMed ID: 36190198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing.
    Pandey P; Setya D; Srivastava R; Singh MK
    Immunohematology; 2020 Jan; 36(1):19-28. PubMed ID: 32324041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the conventional tube test and column agglutination technology for ABO antibody titration in healthy individuals: a report from India.
    Datta SS; Basu S; Reddy M; Gupta K; Sinha S
    Immunohematology; 2021 Mar; 37(1):25-32. PubMed ID: 33962486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to incompatible cross-matched red cells: Our experience in a major regional blood transfusion center at Kolkata, Eastern India.
    Bhattacharya P; Samanta E; Afroza N; Naik A; Biswas R
    Asian J Transfus Sci; 2018; 12(1):51-56. PubMed ID: 29563676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term kidney graft survival across a positive historic but negative current sensitized cross-match.
    Baron C; Pastural M; Lang P; Bentabet R; el-Kassar N; Seror T; Dahmane D; Desvaux D; Chopin D; Fruchaud G; Remy P; Grimbert P; Lepage E; Bierling P
    Transplantation; 2002 Jan; 73(2):232-6. PubMed ID: 11821736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic transfusion reaction due to anti-Jk(a).
    Vucelic D; Savic N; Djordjevic R
    Acta Chir Iugosl; 2005; 52(3):111-5. PubMed ID: 16813007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
    Kerman RH; Susskind B; Buyse I; Pryzbylowski P; Ruth J; Warnell S; Gruber SA; Katz S; Van Buren CT; Kahan BD
    Transplantation; 1999 Dec; 68(12):1855-8. PubMed ID: 10628764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between enzyme-linked immunosorbent assay and cytotoxic cross-match procedures for detecting IgG anti-donor antibodies.
    Susskind B; Kerman RH; Nelson R; Gregory J; La T; Bayat A; Dang M; Van Buren C; Katz S; Kahan BD
    Transplantation; 1998 Dec; 66(12):1823-6. PubMed ID: 9884282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red Cell Alloantibody Screening: Comparative Analysis of Three Different Technologies.
    Orlando N; Bianchi M; Valentini CG; Maresca M; Massini G; Putzulu R; Zini G; Teofili L
    Transfus Med Hemother; 2018 May; 45(3):179-183. PubMed ID: 29928173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.
    Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S
    Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolution of red cell compatibility testing problems in patients receiving anti-lymphoblast or anti-thymocyte globulin.
    Swanson JL; Issitt CH; Mann EW; Condie RM; Simmons RL; McCullough J
    Transfusion; 1984; 24(2):141-3. PubMed ID: 6710586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India.
    Tiwari AK; Pandey P; Sharma J; Shailja K; Dixit S; Raina V
    Transfus Apher Sci; 2014 Apr; 50(2):230-4. PubMed ID: 24548676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Hemolytic Transfusion Reaction Due to the "Anti-E" Rhesus Antibody in a Patient with Crohn's Disease.
    Ahn A; Hwang SH
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.